Garuda - Garba Rujukan Digital

p-Index From 2021 - 2026

0.23

P-Index

This Author published in this journals

All Journal Indonesian Archives of Biomedical Research (InABR)

Radiana Dhewayani Antarianto

Doctoral Program in Biomedical Science, Universitas Indonesia Fakultas Kedokteran, 10430, Indonesia ; Department of Histology, Universitas Indonesia Fakultas Kedokteran, 10430, Indonesia 4Stem cell and Tissue Engineering Research Cluster, IMERI UI

Author-ID : 4247655

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Published : 1 Documents Claim Missing Document

Claim Missing Document

Articles

The Role of artificial intelligence in designing antibody-based therapy for Covid-19 Wahyu Hidayati; Radiana Dhewayani Antarianto
Indonesian Archives and Biomedical Sciences Vol 1 No 1 (2021): Indonesian Archives and Biomedical Sciences Vol 1(1): 2021
Publisher : Konsorsium Ilmu Biomedik Indonesia (KIBI)

For several decades ago, passive immunization has already proven its ability to treat some diseases, especially pandemic diseases. On the contrary, after antibiotics discovery, the usage of passive immunization becomes neglected. Nowadays, we face a pandemic situation, COVID-19, which needs the possible treatment to save patients lives while medicines and vaccines are under development. By learning from history, passive immunization seems to be the best choice to save patient lives. As a kind of passive immunization, antibody-based therapy successfully treats diseases, including infectious diseases. Several antibody-based therapies are developed, as vast as the technology development, especially after the genetic codes announced. This article highlighted the influence of genomics tools, which helps researchers develop various platforms in developing monoclonal antibodies with high safety and efficiency in production and application.

Co-Authors Wahyu Hidayati

Title

Found 1 Documents
Search

Abstract

Title Search

Found 1 Documents Search

Abstract

Title

Found 1 Documents
Search